Back to top
more

Labcorp (LH)

(Delayed Data from NYSE)

$207.94 USD

207.94
793,521

-0.03 (-0.01%)

Updated Apr 24, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (69 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for LH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Labcorp falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 537 430 1,473 1,321 338
Receivables 2,099 3,017 2,978 3,017 2,025
Notes Receivable 0 0 0 0 0
Inventories 475 471 401 423 245
Other Current Assets 655 707 478 365 374
Total Current Assets 3,765 4,625 5,331 5,125 2,981
Net Property & Equipment 2,912 2,956 2,815 2,730 2,637
Investments & Advances 27 66 61 74 85
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 8 22 21 9
Intangibles 9,485 12,068 11,694 11,713 11,900
Deposits & Other Assets 537 433 463 410 435
Total Assets 16,725 20,155 20,385 20,072 18,046
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 1,000 301 2 377 415
Accounts Payable 828 935 621 639 632
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 6 6 11 7 8
Accrued Expenses 804 1,069 1,404 1,358 942
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 422 582 559 507 451
Total Current Liabilities 3,225 3,079 2,783 3,079 2,656
Mortgages 0 0 0 0 0
Deferred Taxes/Income 418 736 763 905 943
Convertible Debt 0 0 0 0 0
Long-Term Debt 4,055 5,039 5,417 5,419 5,790
Non-Current Capital Leases 79 84 85 84 91
Other Non-Current Liabilities 409 423 402 526 383
Minority Interest (Liabilities) 16 19 21 21 20
Total Liabilities 8,850 10,059 10,112 10,712 10,479
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 8 8 9 9 9
Capital Surplus 38 0 0 110 27
Retained Earnings 7,888 10,582 10,457 9,402 7,904
Other Equity -59 -493 -192 -162 -372
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 7,875 10,097 10,273 9,360 7,567
Total Liabilities & Shareholder's Equity 16,725 20,155 20,385 20,072 18,046
Total Common Equity 7,875 10,097 10,273 9,360 7,567
Shares Outstanding 84.90 88.60 95.70 97.40 97.10
Book Value Per Share 92.76 113.96 107.35 96.10 77.93

Fiscal Year End for Labcorp falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 537 728 1,931 394
Receivables NA 2,099 2,065 2,043 3,050
Notes Receivable NA 0 0 0 0
Inventories NA 475 461 488 481
Other Current Assets NA 655 700 660 770
Total Current Assets NA 3,765 3,954 5,121 4,695
Net Property & Equipment NA 2,912 2,821 2,762 2,944
Investments & Advances NA 27 40 67 66
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 8 6 8
Intangibles NA 9,485 9,608 9,336 12,028
Deposits & Other Assets NA 537 457 426 459
Total Assets NA 16,725 16,886 17,719 20,200
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 1,000 991 301 301
Accounts Payable NA 828 691 713 881
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 6 6 7 6
Accrued Expenses NA 804 690 658 930
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 422 361 350 587
Total Current Liabilities NA 3,225 2,901 2,183 2,886
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 418 500 565 737
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 4,055 4,428 5,042 5,052
Non-Current Capital Leases NA 79 80 82 82
Other Non-Current Liabilities NA 423 419 414
Minority Interest (Liabilities) NA 16 19 20 19
Total Liabilities NA 8,850 9,013 8,934 9,859
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 8 8 8 8
Capital Surplus NA 38 5 94 48
Retained Earnings NA 7,888 8,070 8,836 10,730
Other Equity NA -59 -209 -154 -444
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 7,875 7,873 8,785 10,342
Total Liabilities & Shareholder's Equity NA 16,725 16,886 17,719 20,200
Total Common Equity 0 7,875 7,873 8,785 10,342
Shares Outstanding 84.10 84.90 84.90 88.60 88.50
Book Value Per Share 0.00 92.76 92.73 99.15 116.85